Related Experiment Video

Updated: Jun 8, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

The mutator phenotype in cancer: molecular mechanisms and targeting strategies

Marc J Prindle1, Edward J Fox, Lawrence A Loeb

  • 1Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Current Drug Targets
|September 16, 2010
PubMed

Insights

Cancer cells exhibit a mutator phenotype, accumulating numerous DNA mutations. Targeting this increased mutation rate offers novel therapeutic strategies for cancer chemotherapy.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Normal human cells maintain high DNA replication fidelity, with rare errors.
  • Malignant cells display extensive chromosomal abnormalities and numerous DNA sequence alterations.
  • A significant disparity exists between mutation rates in normal versus cancer cells.

Purpose of the Study:

  • To hypothesize and explore the mutator phenotype in cancer development.
  • To investigate the mutator phenotype as a potential therapeutic target.
  • To examine how increased mutation frequency in tumors can inform cancer chemotherapy.

Main Methods:

  • Reviewing evidence supporting the mutator phenotype hypothesis in cancer.
  • Analyzing the role of increased random mutations in tumor evolution.
  • Exploring novel therapeutic approaches based on mutation rates.

Main Results:

  • Cancer cells exhibit a mutator phenotype, characterized by a high rate of DNA mutations.
  • This mutator phenotype is a defining feature of cancer, distinct from normal cells.
  • The accumulation of mutations in cancer cells presents unique therapeutic vulnerabilities.

Conclusions:

  • The mutator phenotype hypothesis provides a framework for understanding cancer evolution.
  • Modulating mutation rates presents a promising avenue for cancer treatment strategies.
  • Targeting the mutator phenotype could lead to more effective cancer chemotherapy designs.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...